|
|
| Phases of Development | Discovery | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Registration | Marketed |
|---|
| Cancer | 1 | 12 | 11 | 4 | 9 | 4 | 2 | 1 | | Cardiovascular | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Dermatology | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | | Diagnostic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Genitourinary | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Neurology | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Other | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | | Renal | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Epidermal growth factor receptor (EGFR)